-+ 0.00%
-+ 0.00%
-+ 0.00%
Science, which develops retinal chips to help elderly blind patients recover some of their eyesight, is valued at $3.5 billion after a new round of financing. The company said the $400 million funding round will continue to develop implant devices to treat blindness and develop neurological devices that use engineered cells to directly connect to the brain. According to the company, the valuation already includes this round of additional capital. Investors in this round include Kosla Ventures, Tenet Healthcare, and the Ackerman-Oxman Institute, a brain research institution founded by hedge fund billionaire Bill Ackman and his wife Neri Oxman this year.
Share
Listen to the news
Science, which develops retinal chips to help elderly blind patients recover some of their eyesight, is valued at $3.5 billion after a new round of financing. The company said the $400 million funding round will continue to develop implant devices to treat blindness and develop neurological devices that use engineered cells to directly connect to the brain. According to the company, the valuation already includes this round of additional capital. Investors in this round include Kosla Ventures, Tenet Healthcare, and the Ackerman-Oxman Institute, a brain research institution founded by hedge fund billionaire Bill Ackman and his wife Neri Oxman this year.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending